RXST
Rxsight Inc
4.80$
-3.1%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.8% | +3.3% | +18.2% | +30.2% | -11.4% | -5.8% | -11.2% | -9.8% | +7.5% | -5.3% | +9.2% | – | |
| – | -35.5% | -19.2% | +20.5% | +89.8% | -43.4% | -16.3% | -11.7% | -27.6% | +20.1% | +0.7% | +6.2% | – | |
| – | +28.6% | +17.2% | +17.2% | +4.0% | +14.1% | -1.6% | -11.1% | -3.8% | +4.3% | -7.0% | +10.2% | – | |
| – | +3.4% | +9.4% | +3.2% | +6.6% | +4.2% | +12.6% | -1.4% | -11.3% | -1.7% | +6.4% | -2.5% | – | |
| – | +10.6% | +10.2% | +4.2% | +5.4% | +10.2% | +1.5% | +1.2% | -5.6% | +1.3% | +15.0% | -4.5% | – | |
| – | +8.6% | +10.0% | +3.9% | +5.7% | +8.6% | +4.2% | +0.5% | -7.1% | +0.5% | +12.9% | -4.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -98.3% | +50.0% | +0.0% | -16.7% | +0.0% | +20.0% | -16.7% | -20.0% | +25.0% | -40.0% | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -250.0% | – | +77.8% | -18.8% | -7.7% | +50.0% | +77.8% | -68.8% | -40.0% | +0.0% | +1,366.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.